ArticleJournal of virology2023
Virology under the Microscope-a Call for Rational Discourse.
Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Public trust in science has declined since COVID - virologists need to unite around safety standards.Nature · 2025Article
- Principal Investigator Responsibility for Flagging Research with Dual-Use or Pandemic Risk.Applied biosafety : journal of the American Biological Safety Association · 2025Article
- Virologist Opinions: An Important Component for the Governance of the Convergence of Artificial Intelligence and Dual-Use Research of Concern.Applied biosafety : journal of the American Biological Safety Association · 2025Article
- Future pandemics and the urge to 'do something'.Journal of medical ethics · 2025Article
- The Application of DNA Viruses to Biotechnology.Viruses · 2025Review
- Development of learning objectives to support undergraduate virology curriculum guidelines.Journal of microbiology & biology education · 2024Article
- Dual-use research and research using enhanced pathogens in high-income countries: whose business?mSphere · 2024Article
- SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs.Cell chemical biology · 2024Review
- Virology-the path forward.Journal of virology · 2024Article
- Article
- Article
- Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".mSphere · 2023Article
- Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".Journal of virology · 2023Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
156 authors.
Funding
Abstract
Viruses have brought humanity many challenges: respiratory infection, cancer, neurological impairment and immunosuppression to name a few. Virology research over the last 60+ years has responded to reduce this disease burden with vaccines and antivirals. Despite this long history, the COVID-19 pandemic has brought unprecedented attention to the field of virology. Some of this attention is focused on concern about the safe conduct of research with human pathogens. A small but vocal group of individuals has seized upon these concerns - conflating legitimate questions about safely conducting virus-related research with uncertainties over the origins of SARS-CoV-2. The result has fueled public confusion and, in many instances, ill-informed condemnation of virology. With this article, we seek to promote a return to rational discourse. We explain the use of gain-of-function approaches in science, discuss the possible origins of SARS-CoV-2 and outline current regulatory structures that provide oversight for virological research in the United States. By offering our expertise, we - a broad group of working virologists - seek to aid policy makers in navigating these controversial issues. Balanced, evidence-based discourse is essential to addressing public concern while maintaining and expanding much-needed research in virology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.